KALA BIO, INC. Basic Shares Outstanding (Weighted Average)
KALA BIO, INC. (KALA) reported Basic Shares Outstanding (Weighted Average) of 74.16 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-19
- KALA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 74.16K shares, a 43.07% decline year-over-year.
- KALA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.87M shares, a 9255.38% increase year-over-year.
- KALA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 12.68M shares, a 169.81% increase year-over-year.
- KALA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.04M shares, a 52.18% increase year-over-year.
- KALA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 8.15M shares, a 114.65% increase from fiscal 2024.
- KALA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 3.80M shares, a 56.09% increase from fiscal 2023.
- KALA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 2.43M shares, a 59.94% increase from fiscal 2022.
- KALA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 1.52M shares, a 15.50% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 74.16K shares 10-Q · filed 2026-08-19 | 15.29M shares 10-Q · filed 2026-08-19 | 8.21M shares derived: average of 3 quarters · filed 2026-08-19 | 7.92M shares derived: average of 4 quarters · filed 2026-08-19 | |||
| 2026-03-31 | 11.87M shares 10-Q · filed 2026-05-15 | 12.28M shares derived: average of 2 quarters · filed 2026-05-15 | 10.53M shares derived: average of 3 quarters · filed 2026-05-15 | 7.93M shares derived: average of 4 quarters · filed 2026-08-19 | |||
| 2025-12-31 | 12.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 9.86M shares derived: average of 2 quarters · filed 2026-04-15 | 6.62M shares derived: average of 3 quarters · filed 2026-08-19 | 8.15M shares 10-K · filed 2026-04-15 | |||
| 2025-09-30 | 7.04M shares 10-Q · filed 2025-11-19 | 3.59M shares derived: average of 2 quarters · filed 2026-08-19 | 6.64M shares 10-Q · filed 2025-11-19 | 3.00M shares derived: average of 4 quarters · filed 2026-08-19 | |||
| 2025-06-30 | 130.26K shares 10-Q · filed 2026-08-19 | 6.51M shares 10-Q · filed 2025-08-08 | 128.60K shares 10-Q · filed 2026-08-19 | 6.43M shares 10-Q · filed 2025-08-08 | 1.65M shares derived: average of 3 quarters · filed 2026-08-19 | 2.40M shares derived: average of 4 quarters · filed 2026-08-19 | |
| 2025-03-31 | 126.92K shares 10-Q · filed 2026-05-15 | 6.35M shares 10-Q · filed 2025-05-14 | 2.41M shares derived: average of 2 quarters · filed 2026-05-15 | 3.15M shares derived: average of 3 quarters · filed 2026-05-15 | 3.12M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | 4.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 4.66M shares derived: average of 2 quarters · filed 2026-04-15 | 4.12M shares derived: average of 3 quarters · filed 2026-04-15 | 3.80M shares 10-K · filed 2026-04-15 | |||
| 2024-09-30 | 4.63M shares 10-Q · filed 2025-11-19 | 3.83M shares derived: average of 2 quarters · filed 2025-11-19 | 3.49M shares 10-Q · filed 2025-11-19 | 3.30M shares derived: average of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | 3.03M shares 10-Q · filed 2025-08-08 | 2.92M shares 10-Q · filed 2025-08-08 | 2.85M shares derived: average of 3 quarters · filed 2025-08-08 | 2.78M shares derived: average of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | 2.81M shares 10-Q · filed 2025-05-14 | 2.76M shares derived: average of 2 quarters · filed 2025-05-14 | 2.69M shares derived: average of 3 quarters · filed 2025-05-14 | 2.62M shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | 2.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 2.63M shares derived: average of 2 quarters · filed 2025-03-31 | 2.55M shares derived: average of 3 quarters · filed 2025-03-31 | 2.43M shares 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 2.55M shares 10-Q · filed 2024-11-12 | 2.47M shares derived: average of 2 quarters · filed 2024-11-12 | 2.34M shares 10-Q · filed 2024-11-12 | 2.15M shares derived: average of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | 2.39M shares 10-Q · filed 2024-08-06 | 2.23M shares 10-Q · filed 2024-08-06 | 2.02M shares derived: average of 3 quarters · filed 2024-08-06 | 1.89M shares derived: average of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | 2.07M shares 10-Q · filed 2024-05-14 | 1.84M shares derived: average of 2 quarters · filed 2024-05-14 | 1.73M shares derived: average of 3 quarters · filed 2024-05-14 | 1.67M shares derived: average of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | 1.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 1.56M shares derived: average of 2 quarters · filed 2024-03-29 | 1.53M shares derived: average of 3 quarters · filed 2024-03-29 | 1.52M shares 10-K · filed 2024-03-29 | |||
| 2022-09-30 | 1.50M shares 10-Q · filed 2023-11-13 | 1.49M shares derived: average of 2 quarters · filed 2023-11-13 | 1.49M shares 10-Q · filed 2023-11-13 | 1.47M shares derived: average of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | 1.49M shares 10-Q · filed 2023-08-04 | 73.68M shares 10-Q · filed 2022-08-11 | 1.49M shares 10-Q · filed 2023-08-04 | 73.66M shares 10-Q · filed 2022-08-11 | 1.46M shares derived: average of 3 quarters · filed 2023-08-04 | 1.42M shares derived: average of 4 quarters · filed 2023-08-04 | |
| 2022-03-31 | 1.49M shares 10-Q · filed 2023-05-09 | 73.64M shares 10-Q · filed 2022-05-16 | 1.44M shares derived: average of 2 quarters · filed 2023-05-09 | 1.40M shares derived: average of 3 quarters · filed 2023-05-09 | 17.19M shares derived: average of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | 1.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | 1.36M shares derived: average of 2 quarters · filed 2023-03-03 | 22.42M shares derived: average of 3 quarters · filed 2023-03-03 | 1.32M shares 10-K · filed 2023-03-03 | 65.20M shares 10-K · filed 2022-03-29 | ||
| 2021-09-30 | 1.31M shares 10-Q · filed 2022-11-08 | 32.93M shares derived: average of 2 quarters · filed 2022-11-08 | 1.29M shares 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | 64.55M shares 10-Q · filed 2022-08-11 | 63.11M shares 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | 61.66M shares 10-Q · filed 2022-05-16 | ||||||
| 2020-12-31 | 52.38M shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |